Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ODC1 | P11926 | 2/20 | 0.42 |
| ▸ | PAOX | Q6QHF9 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | BLM | P54132 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | PLG | P00747 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL522662 | 1.00 | ODC1 (0.42) | ODC1PAOXLMNABLMKDM4E | |
| Hydrochloric Acid SCHEMBL8205380 | 0.98 | BLM (0.43) | ODC1PAOXLMNABLMKDM4E | |
| Hydrochloric Acid SCHEMBL8205379 | 0.98 | BLM (0.43) | ODC1PAOXLMNABLMKDM4E | |
| SCHEMBL3744397 | 0.94 | ODC1 (0.48) | ODC1PAOXLMNABLMKDM4E | |
| SCHEMBL3744393 | 0.94 | ODC1 (0.48) | ODC1PAOXLMNABLMKDM4E | |
| SCHEMBL3627363 | 0.94 | ODC1 (0.48) | ODC1PAOXLMNABLMKDM4E | |
| SCHEMBL9617305 | 0.89 | PAOX (0.44) | ODC1PAOXLMNABLMKDM4E | |
| SCHEMBL449961 | 0.87 | PAOX (0.48) | ODC1PAOXLMNABLMCYP2D6 | |
| SCHEMBL2115160 | 0.87 | ODC1 (0.48) | ODC1PAOXLMNABLMKDM4E | |
| SCHEMBL20636765 | 0.85 | ODC1 (0.38) | ODC1PAOXLMNABLMKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118688315-A | Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds | 复旦大学 | 2024-09-24 | — | — | CN | claimed |
| CN-115060834-B | Serum/plasma metabolism molecular marker related to ICP auxiliary diagnosis and application thereof | 无锡市妇幼保健院 | 2023-11-10 | — | — | CN | claimed |
| US-20220193215-A1 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | THE GENERAL HOSPITAL CORPORATION | 2022-06-23 | — | — | US | claimed |
| CN-110563943-A | Bio-based polymer and preparation method thereof | 中国科学院长春应用化学研究所 | 2019-12-13 | — | — | CN | claimed |
| US-20180296658-A1 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | THE GENERAL HOSPITAL CORPORATION | 2018-10-18 | — | — | US | claimed |
| EP-3355914-A1 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | The General Hospital Corporation (US) | 2018-08-08 | — | — | EP | claimed |
| EP-1750126-B1 | METHOD AND APPARATUS FOR ANALYZING AMINOFUNCTIONAL COMPOUND | AJINOMOTO KK (JP) | 2015-09-16 | — | — | EP | claimed |
| US-20040052803-A1 | Skin cosmetics | SHU UEMURA COSMETICS INC. (JP) | 2004-03-18 | — | — | US | claimed |
| EP-1344515-A1 | SKIN COSMETICS | Shu Uemura Cosmetics Inc. (JP) | 2003-09-17 | — | — | EP | claimed |
| EP-0723552-B1 | OLIGOPEPTIDES DERIVED FROM C-REACTIVE PROTEIN FRAGMENTS | ITALFARMACO SPA (IT) | 2002-10-23 | — | — | EP | claimed |
| US-6342481-B1 | RESIDUES OF THREONINE, LEUCINE, ISOLEUCINE, VALINE, SARCOSINE, ALANINE, GLYCINE AND ACYLGLYCINE | ITALFARMACO S.P.A. (IT) | 2002-01-29 | — | — | US | claimed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | claimed |
| CN-121518365-A | Method for promoting generation of characteristic metabolites of akkermansia muciniphila | 集美大学 | 2026-02-13 | — | — | CN | disclosed |
| CN-118858500-A | Method for detecting metabolites of triangular bream fertilized eggs in different developmental stages | 浙江省农业科学院 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024206366-A2 | GENETICALLY ENCODED SYSTEM FOR QUANTIFYING RUBISCO ACTIVITY IN CATALYZING CARBON FIXATION | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-03 | — | — | WO | disclosed |
| CN-118688315-A | Multichannel high-coverage synchronous quantification method for amino-containing and hydroxyl-containing compounds | 复旦大学 | 2024-09-24 | — | — | CN | disclosed |
| WO-1999027979-A1 | METHOD FOR INHIBITING CALCIFICATION OF ALDEHYDE-FIXED BIOPROSTHETIC MATERIALS | BAXTER INTERNATIONAL INC. (US) | 1999-06-10 | — | — | WO | disclosed |
| WO-1998010292-A1 | MONOCLONAL ANTIBODIES SPECIFIC FOR PROSTATE SPECIFIC ANTIGEN AND METHODS OF DETECTING PROSTATE SPECIFIC ANTIGEN | CENTOCOR, INC. (US) | 1998-03-12 | — | — | WO | disclosed |
| US-5284872-A | Nitrato alkanoic acid derivatives, methods for their production, pharmaceutical compositions containing the derivatives and medicinal uses thereof | SCHWARZ PHARMA AG (DE) | 1994-02-08 | — | — | US | disclosed |
| US-4837166-A | REACTING SUBSTITUTED OR UNSUBSTITUTED NAPHTHALENE-2,3-DICARBOXYALDEHYDE OR O-PHTHALALDEHYDE WITH CYANIDE AND PRIMARY AMINE | OREAD LABORATORIES, INC. (US) | 1989-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193215-A1 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | LDLR, HMGCR, PCSK9 | ODC1 3120/4885PAOX 1673/4885LMNA 3884/4885 |
| US-20180296658-A1 | METHODS OF TREATING AND DIAGNOSING DISEASE USING BIOMARKERS FOR BCG THERAPY | LDLR, HMGCR, PCSK9 | ODC1 3120/4885PAOX 1673/4885LMNA 3884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.